{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:57:55Z","timestamp":1791082675198,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"American Association of College of Pharmacy (AACP) New Investigator Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00213-019-05401-1","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T09:03:36Z","timestamp":1600074216000},"page":"3215-3224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior"],"prefix":"10.1007","volume":"237","author":[{"given":"Meng-Jia","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong-Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Ming","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"5401_CR1","volume-title":"StatPearls","author":"C Bruggeman","year":"2018","unstructured":"Bruggeman C, O\u2019Day CS (2018) Selective serotonin reuptake inhibitor (SSRI) toxicity. In: StatPearls. StatPearls PublishingStatPearls Publishing LLC, Treasure Island (FL)"},{"key":"5401_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.5664\/jcsm.5876","volume":"12","author":"MS Cepeda","year":"2016","unstructured":"Cepeda MS, Stang P, Blacketer C, Kent JM, Wittenberg GM (2016) Clinical relevance of sleep duration: results from a cross-sectional analysis using NHANES. J Clin Sleep Med 12:813\u2013819. https:\/\/doi.org\/10.5664\/jcsm.5876","journal-title":"J Clin Sleep Med"},{"key":"5401_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/bcp.12829","volume":"81","author":"B Danielsson","year":"2016","unstructured":"Danielsson B, Collin J, Jonasdottir Bergman G, Borg N, Salmi P, Fastbom J (2016) Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study. Br J Clin Pharmacol 81:773\u2013783. https:\/\/doi.org\/10.1111\/bcp.12829","journal-title":"Br J Clin Pharmacol"},{"key":"5401_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.17116\/jnevro201711791103-111","volume":"117","author":"DS Danilov","year":"2017","unstructured":"Danilov DS (2017) Multimodal serotonergic antidepressants. Zh Nevrol Psikhiatr Im S S Korsakova 117:103\u2013111. https:\/\/doi.org\/10.17116\/jnevro201711791103-111","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"5401_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbr.2014.03.042","volume":"268","author":"L Ding","year":"2014","unstructured":"Ding L et al (2014) Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanisms. Behav Brain Res 268:150\u2013158. https:\/\/doi.org\/10.1016\/j.bbr.2014.03.042","journal-title":"Behav Brain Res"},{"key":"5401_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10571-011-9788-9","volume":"32","author":"P Filipcik","year":"2012","unstructured":"Filipcik P, Novak P, Mravec B, Ondicova K, Krajciova G, Novak M, Kvetnansky R (2012) Tau protein phosphorylation in diverse brain areas of normal and CRH deficient mice: up-regulation by stress. Cell Mol Neurobiol 32:837\u2013845. https:\/\/doi.org\/10.1007\/s10571-011-9788-9","journal-title":"Cell Mol Neurobiol"},{"key":"5401_CR7","first-page":"57","volume":"75","author":"BN Gaynes","year":"2008","unstructured":"Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M (2008) The STAR*D study: treating depression in the real world Cleveland Clinic. J Med 75:57\u201366","journal-title":"J Med"},{"key":"5401_CR8","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.4088\/JCP.9078tx1c","volume":"71","author":"AJ Gelenberg","year":"2010","unstructured":"Gelenberg AJ (2010) A review of the current guidelines for depression treatment. J Clin Psychiatry 71:e15. https:\/\/doi.org\/10.4088\/JCP.9078tx1c","journal-title":"J Clin Psychiatry"},{"key":"5401_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/cns.12864","volume":"24","author":"XF Huang","year":"2018","unstructured":"Huang XF et al (2018) A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling. CNS Neurosci Therapeut 24:889\u2013896. https:\/\/doi.org\/10.1111\/cns.12864","journal-title":"CNS Neurosci Therapeut"},{"key":"5401_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-0404.2006.00579.x","volume":"113","author":"L Ishihara","year":"2006","unstructured":"Ishihara L, Brayne C (2006) A systematic review of depression and mental illness preceding Parkinson\u2019s disease. Acta Neurol Scand 113:211\u2013220. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00579.x","journal-title":"Acta Neurol Scand"},{"key":"5401_CR11","doi-asserted-by":"publisher","unstructured":"Kennedy SH (2013) A review of antidepressant therapy in primary care: current practices and future directions. Prim Care Comp CNS Dis 15. https:\/\/doi.org\/10.4088\/PCC.12r01420","DOI":"10.4088\/PCC.12r01420"},{"key":"5401_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1038\/npp.2009.66","volume":"34","author":"YF Li","year":"2009","unstructured":"Li YF, Huang Y, Amsdell SL, Xiao L, O\u2019Donnell JM, Zhang HT (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34:2404\u20132419. https:\/\/doi.org\/10.1038\/npp.2009.66","journal-title":"Neuropsychopharmacology"},{"key":"5401_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.lfs.2008.12.008","volume":"84","author":"J Liu","year":"2009","unstructured":"Liu J, Li L, Suo WZ (2009) HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Life Sci 84:267\u2013271. https:\/\/doi.org\/10.1016\/j.lfs.2008.12.008","journal-title":"Life Sci"},{"key":"5401_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/cns.12863","volume":"24","author":"L Liu","year":"2018","unstructured":"Liu L et al (2018) The neuroprotective and antidepressant-like effects of Hcyb1, a novel selective PDE2 inhibitor. CNS Neurosci Therapeut 24:652\u2013660. https:\/\/doi.org\/10.1111\/cns.12863","journal-title":"CNS Neurosci Therapeut"},{"key":"5401_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","volume":"109","author":"C Lugnier","year":"2006","unstructured":"Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109:366\u2013398. https:\/\/doi.org\/10.1016\/j.pharmthera.2005.07.003","journal-title":"Pharmacol Ther"},{"key":"5401_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1124\/jpet.108.137208","volume":"326","author":"A Masood","year":"2008","unstructured":"Masood A, Nadeem A, Mustafa SJ, O\u2019Donnell JM (2008) Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther 326:369\u2013379. https:\/\/doi.org\/10.1124\/jpet.108.137208","journal-title":"J Pharmacol Exp Ther"},{"key":"5401_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1043-2760(01)00523-9","volume":"13","author":"C Mehats","year":"2002","unstructured":"Mehats C, Andersen CB, Filopanti M, Jin SL, Conti M (2002) Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab 13:29\u201335","journal-title":"Trends Endocrinol Metab"},{"key":"5401_CR18","doi-asserted-by":"crossref","unstructured":"Pratt LA, Brody DJ (2008) Depression in the United States household population, 2005-2006. NCHS data brief:1\u20138","DOI":"10.1037\/e565102009-001"},{"key":"5401_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L et al (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (New York, NY) 301:805\u2013809. https:\/\/doi.org\/10.1126\/science.1083328","journal-title":"Science (New York, NY)"},{"key":"5401_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0270(94)00155-A","volume":"58","author":"R Sapolsky","year":"1995","unstructured":"Sapolsky R, Brooke S, Stein-Behrens B (1995) Methodologic issues in studying glucocorticoid-induced damage to neurons. J Neurosci Methods 58:1\u201315","journal-title":"J Neurosci Methods"},{"key":"5401_CR21","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1111\/j.1460-9568.2004.03793.x","volume":"20","author":"C Werner","year":"2004","unstructured":"Werner C et al (2004) Importance of NO\/cGMP signalling via cGMP-dependent protein kinase II for controlling emotionality and neurobehavioural effects of alcohol. Eur J Neurosci 20:3498\u20133506. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03793.x","journal-title":"Eur J Neurosci"},{"key":"5401_CR22","doi-asserted-by":"publisher","first-page":"37928","DOI":"10.1074\/jbc.M404287200","volume":"279","author":"AY Wu","year":"2004","unstructured":"Wu AY, Tang XB, Martinez SE, Ikeda K, Beavo JA (2004) Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A. J Biol Chem 279:37928\u201337938. https:\/\/doi.org\/10.1074\/jbc.M404287200","journal-title":"J Biol Chem"},{"key":"5401_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2005.06.002","volume":"518","author":"Y Xu","year":"2005","unstructured":"Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005) The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518:40\u201346. https:\/\/doi.org\/10.1016\/j.ejphar.2005.06.002","journal-title":"Eur J Pharmacol"},{"key":"5401_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neuropharm.2009.06.010","volume":"57","author":"Y Xu","year":"2009","unstructured":"Xu Y et al (2009) Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress. Neuropharmacology 57:463\u2013471. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.06.010","journal-title":"Neuropharmacology"},{"key":"5401_CR25","doi-asserted-by":"publisher","unstructured":"Xu Y, Zhang HT, O\u2019Donnell JM (2011) Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders. Handb Exp Pharmacol:447\u2013485. https:\/\/doi.org\/10.1007\/978-3-642-17969-3_19","DOI":"10.1007\/978-3-642-17969-3_19"},{"key":"5401_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1017\/s146114571200065x","volume":"16","author":"Y Xu","year":"2013","unstructured":"Xu Y et al (2013) Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP\/PKG dependent pathway. Int J Neuropsychopharmacol 16:835\u2013847. https:\/\/doi.org\/10.1017\/s146114571200065x","journal-title":"Int J Neuropsychopharmacol"},{"key":"5401_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neurobiolaging.2014.08.028","volume":"36","author":"Y Xu","year":"2015","unstructured":"Xu Y et al (2015) Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress. Neurobiol Aging 36:955\u2013970. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.08.028","journal-title":"Neurobiol Aging"},{"key":"5401_CR28","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/15287394.2018.1504384","volume":"81","author":"M Zhang","year":"2018","unstructured":"Zhang M et al (2018) Involvement of nerve growth factor in mouse hippocampal neuronal cell line (HT22) differentiation and underlying role of DNA methyltransferases. J Toxicol Environ Health Part A 81:1116\u20131122. https:\/\/doi.org\/10.1080\/15287394.2018.1504384","journal-title":"J Toxicol Environ Health Part A"},{"key":"5401_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1742-7843.2008.00369.x","volume":"104","author":"H Zhou","year":"2009","unstructured":"Zhou H, Li X, Gao M (2009) Curcumin protects PC12 cells from corticosterone-induced cytotoxicity: possible involvement of the ERK1\/2 pathway. Basic Clin Pharmacol Toxicol 104:236\u2013240. https:\/\/doi.org\/10.1111\/j.1742-7843.2008.00369.x","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-019-05401-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T23:25:18Z","timestamp":1631575518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-019-05401-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5401"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05401-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were conducted based on the \u201cNIH Guide for the Care and Use of Laboratory Animals\u201d (NIH Publications Number 80-23, revised 1996) and were approved by the Institutional Animal Care and Use Committee of the University at Buffalo.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}